J. Christopher Naftzger - General Counsel and Corp Sec, Nabriva Therapeutics Plc
As of February 1, 2022
J. Christopher Naftzger Net Worth
- Net worth is estimated to be at least $34.58K
- Owns at least 7,000 units of Nabriva Therapeutics Plc stock
J. Christopher Naftzger Compensation at Nabriva Therapeutics Plc in 2020
- Earned a $460,000 salary and a $100 bonus
- Received a total compensation of $1,074,113
J. Christopher Naftzger Trading
- Largest purchase of shares was 7,000 units , worth over $4.13K on December 28, 2021
- In total has made about 3 transactions over a year
- Usually trades in October, February and December, with the busiest year in 2021
J. Christopher Naftzger
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
J. Christopher Naftzger Mailing Address
- Mailing address is 633 Lowther Road Lewisberry PA 17339 PA
Nabriva Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Theodore Schroeder | 2020 | $576,800 | - | $242,256 | $339,625 | $242,256 | $31,759 | $1,654,570 |
| Theodore Schroeder | 2019 | $560,000 | - | $119,250 | $478,367 | $119,250 | $28,372 | $1,496,164 |
| Steven Gelone | 2020 | $486,300 | - | $153,185 | $231,493 | $153,185 | $12,675 | $1,154,516 |
| Steven Gelone | 2019 | $472,100 | - | $181,420 | $309,859 | $181,420 | $13,976 | $1,178,280 |
| Jennifer Schranz | 2020 | $460,000 | $100,000 | $145,203 | $156,818 | $145,203 | $28,604 | $1,074,113 |
| Jennifer Schranz | 2019 | $436,200 | - | $151,200 | $261,555 | $151,200 | $33,450 | $982,155 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm
Nabriva Therapeutics Plc Insider Trading
- The most recent transaction was 100,000 units bought on December 29, 2021 by Theodore Schroeder worth over $57.32K
- In the last 4 years, insiders at Nabriva Therapeutics Plc sold an estimated value of $5.25M and bought an estimated value of $1.22M
- The most active traders are Steven Gelone, President and COO, Theodore Schroeder, Chief Executive Officer, and Robert Crotty, Gen Counsel & Corp Secretary
- Insider trading is most common in August, with the busiest year in 2021
Nabriva Therapeutics plc Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||